Author： Hayashi Yoshiro Roberts Jason A Paterson David L Lipman Jeffrey
Publisher： Informa Healthcare
ISSN： 1742-5255
Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.6, Iss.8, 2010-08, pp. : 1017-1031
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Piperacillin/tazobactam: Myelosuppression: case report
Reactions Weekly, Vol. 1, Iss. 1218, 2008-01 ,pp. :
Access to resources
Recommend
Piperacillin/tazobactam: Thrombocytopenia: case report
Reactions Weekly, Vol. 1, Iss. 1425, 2012-01 ,pp. :
Caution issued for use of generic piperacillin/tazobactam.
Reactions Weekly, Vol. 1, Iss. 1236, 2009-01 ,pp. :
Piperacillin/tazobactam: Toxic epidermal necrolysis: case report
Reactions Weekly, Vol. 1, Iss. 1334, 2011-01 ,pp. :
Piperacillin/tazobactam: extended infusion "good alternative"
Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. :